MD Anderson ranked No. 1 in the nation for cancer care
Top ranking maintained for 11 years
National rankings in multiple subspecialties and high performing ratings for several procedures and conditions achieved
Ranking reflects commitment to excellence in cancer patient care
The University of Texas MD Anderson Cancer Center today was ranked number one in the nation for cancer care in U.S. News & World Report’s 2025-2026 “Best Hospitals” survey. The institution has...
AACR: MD Anderson’s Scott Kopetz and Elizabeth Travis honored with 2024 Scientific Achievement Awards
Two researchers from The University of Texas MD Anderson Cancer Center will be honored with Scientific Achievement Awards at the American...
MD Anderson Research Highlights for January 25, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention...
MD Anderson ranked #1 in the nation for cancer care
The University of Texas MD Anderson Cancer Center today was named number one in the nation for cancer care in U.S. News & World Report’s 2023-24 “Best Hospitals” survey. The institution has been one of the nation’s top two hospitals for cancer care since the survey’s inception in 1990.
“At MD Anderson, we remain singularly focused on eliminating cancer,” said Peter WT Pisters, M.D., president of MD Anderson. “We are pleased...
MD Anderson named #1 in the nation for cancer care
The University of Texas MD Anderson Cancer Center today was named number one in the nation for cancer care in U.S. News & World Report...
Targeted therapy pralsetinib achieves high response rates in advanced cancers with RET gene fusions
ABSTRACT: #109
The targeted therapy pralsetinib appears to have high response rates and durable activity in patients with a broad variety...
Quality of care for older Texas patients with colon cancer on the rise, still room for improvement
Research from The University of Texas MD Anderson Cancer Center finds adherence to surgical treatment guidelines has improved significantly...
MD Anderson and EMD Serono enter three-year strategic collaboration to accelerate development of investigational oncology/immuno-oncology compounds
The University of Texas MD Anderson Cancer Center and EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and...
Moon Shots Program APOLLO project aims to expose cancer’s evasive action
A study that indicates how advanced melanoma responds to an immunotherapy, published in Cancer Discovery, demonstrates a revolutionary...
Advances in endoscopy field allows most patients with complex colon polyps to avoid surgery, MD Anderson study finds
Using the latest advances in endoscopic resection techniques, more than 75 percent of patients with complex colon polyps could avoid surgery...